Logo
x

Search category

Subscribe Now

P-II trial

Daiichi Sankyo Initiates P-II Trial of Pexidartinib for Tenosynovial Giant Cell Tumor in Japan

Daiichi Sankyo Initiates P-II Trial of Pexidartinib for Tenosynovial Giant Cell Tumor in Japan

  • April 12, 2021
Allergen Announces Acquisition of Bonti for its Two Aesthetic and Therapeutic Products

Allergen Announces Acquisition of Bonti for its Two Aesthetic and Therapeutic Products

  • September 17, 2018
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.